Risk factors and prevalence of cognitive deficits in women with gynecologic malignancies.

9601 Background: Cognitive impairment has implications in counseling, treatment, and survivorship for women with gynecologic malignancies. The purpose of our study was to evaluate prevalence and risk factors associated with cognitive impairment. Methods: After IRB approval, 165 women at an urban ambulatory facility were queried using a Montreal Cognitive Assessment (MOCA), Depression Scale, Wong-Baker pain scale, and neuropathy scale. The association of cognitive deficit with age, education, race/ethnicity, disease site, stage, treatment, pain, neuropathy, anxiety and depression was evaluated. Results: Mean MOCA score was 24.1 (range 13-30.) 24% of patients had MOCA scores less than 22. Low scores ( 5 (p<0.05). There was a trend toward lower scores for with chemotherapy and radiation treatment (p=0.10). Low cognition scores were not associated with pain medication use. Conclusions: There was a h...